NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB)

CUSIP: 63937X103

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Equity / COM
Total 13F shares
12,063,015
Share change
-876,420
Total reported value
$2,758,000
Price per share
$0.23
Number of holders
42
Value change
-$222,542
Number of buys
9
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 63937X103?
CUSIP 63937X103 identifies NAVB - NAVIDEA BIOPHARMACEUTICALS I - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB) as of Q2 2018

As of 30 Jun 2018, NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB) was held by 42 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,063,015 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., Harel Insurance Investments & Financial Services Ltd., GEODE CAPITAL MANAGEMENT, LLC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, JACOBS LEVY EQUITY MANAGEMENT, INC, NORTHERN TRUST CORP, WEDBUSH SECURITIES INC, CITADEL ADVISORS LLC, and MORGAN STANLEY. This page lists 42 institutional shareholders reporting positions in this security for the Q2 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.